Azithromycin`s association with cardiac events also has been debated. In 2012, the FDA issued a warning for azithromycin stating that it had been linked to cardiac events, but subsequent studies have yielded mixed results.
from Azithromycin, potential COVID-19 drug, may increase risk for cardiac events https://ift.tt/3c7HT5P
https://ift.tt/eA8V8J
from Azithromycin, potential COVID-19 drug, may increase risk for cardiac events https://ift.tt/3c7HT5P
https://ift.tt/eA8V8J
No comments:
Post a Comment